Novo Nordisk is the principal defendant, with Eli Lilly named in connection with Trulicity in related vision loss cases
Hold the pen or autoinjector at a 90-degree angle to your skin (perpendicular), insert the needle with a quick, dart-like motion, and inject the medication according to your device's instructions
Feel Less Nauseous After Your GLP-1 Shot A practical, no-guesswork meal and recovery kit for GLP-1 users who are tired of crackers, skipped meals, and wasted weekends
In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
Both have gained global attention for their ability to potentially aid substantial weight loss
Medical screening at our Ponte Vedra office identifies any contraindications